Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials
Show More
European Journal of Cancer
,
Volume 163,
pp 98-107; https://doi.org/10.1016/j.ejca.2021.11.017
The publisher has not yet granted permission to display this abstract.
Keywords: Drug development / CNS cancers / Glioblastoma / Precision medicine / Phase I
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "European Journal of Cancer" .